Invention Grant
![Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists](/docs/US/2021-06-08/US11028085B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists
-
Application No.: US17020050Application Date: 2020-09-14
-
Publication No.: US11028085B2Publication Date: 2021-06-08
- Inventor: Neelu Kaila , Ian Linney , Stuart Ward , Grant Wishart , Ben Whittaker , Alexandre Cote , Jeremy Robert Greenwood , Abba Leffler , Steven K. Albanese , Daniel L. Severance
- Applicant: Nimbus Saturn, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Nimbus Saturn, Inc.
- Current Assignee: Nimbus Saturn, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Dechert LLP
- Agent Andrea L.C. Reid; Paul R. Fleming
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D471/04 ; A61K31/437 ; C07D519/00
![Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists](/abs-image/US/2021/06/08/US11028085B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
Public/Granted literature
- US20210087189A1 SUBSTITUTED ISINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROLO[3,3-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS Public/Granted day:2021-03-25
Information query
